diabetes management algorithm step 2 medicine shelf glyburide semaglutide American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type – 2023 Update Diabetes Drugs: Rapid Revision for

Ozempic was trialled as a treatment for type 2 diabetes, although weight loss is a side effect of the drug, and Ozempic is designed for weight management for the clinically obese

Dual Benefits : Many people with type 2 diabetes are overweight, so semaglutide addresses both high blood sugar and weight concerns at the same time

For most adults, yes when started at a low dose and taken with adequate fluid

The rapid growth trajectory from initial filings in August 2023 to nearly 2,000 cases by August 2025 (with more ozempic lawsuits expected) reflects both the widespread use of these medications (with over 33 million patient-years of semaglutide exposure globally) and the severity of reported injuries